Format

Send to

Choose Destination
Open Forum Infect Dis. 2016 May 23;3(2):ofw108. doi: 10.1093/ofid/ofw108. eCollection 2016 Apr.

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine.

Author information

1
Departments of Pediatrics.
2
Epidemiology.
3
Thayer School of Engineering, Dartmouth College , Hanover, New Hampshire.
4
Medicine.
5
Microbiology and Immunology , Geisel School of Medicine at Dartmouth , Lebanon.
6
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland.
7
Human Immune Monitoring Center, Institute for Immunity , Transplantation and Infection, Stanford University , Palo Alto, California.
8
Department of Medicine , University of Rochester , New York.

Abstract

BACKGROUND:

 The efficacy of live, attenuated live attenuated influenza vaccine(LAIV) and inactivated influenza vaccine(IIV) is poorly explained by either single or composite immune responses to vaccination. Protective biomarkers were therefore studied in response to LAIV or IIV followed by LAIV challenge in children.

METHODS:

 Serum and mucosal responses to LAIV or IIV were analyzed using immunologic assays to assess both quantitative and functional responses. Cytokines and chemokines were measured in nasal washes collected before vaccination, on days 2, 4, and 7 after initial LAIV, and again after LAIV challenge using a 63-multiplex Luminex panel.

RESULTS:

 Patterns of immunity induced by LAIV and IIV were significantly different. Serum responses induced by IIV, including hemagglutination inhibition, did not correlate with detection or quantitation of LAIV on subsequent challenge. Modalities that induced sterilizing immunity seen after LAIV challenge could not be defined by any measurements of mucosal or serum antibodies induced by the initial LAIV immunization. No single cytokine or chemokine was predictive of protection.

CONCLUSIONS:

 The mechanism of protective immunity observed after LAIV could not be defined, and traditional measurements of immunity to IIV did not correlate with protection against an LAIV challenge.

KEYWORDS:

humoral immunity; influenza vaccine; mucosal immunity; vaccine

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center